In the same article, C&EN incorrectly characterized Pfizer’s medicinal chemistry hiring plans. Pfizer is looking to enhance its in-house synthetic organic chemical capabilities to complement the talents of its contract research partners. The goal is to build internal synthetic problem solving for particularly challenging molecules.I have to go hunting in my garage for this issue to figure out what Pfizer objected to...
Monday, December 16, 2013
An interesting correction
In this week's C&EN's letters section, an interesting correction from this article by Sophie Rovner: